Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trial
This work was supported by the National Natural Science Foundation of China (No. 82430053); Shanghai Science and Technology Committee, China (Grant No. 24SF1904500); Innovation Program of Shanghai Municipal Education Commission, China (Grant No. 2023ZKZD33, Grant No. AI for Science); Tongji University Medicine-X Interdisciplinary Research Initiative, China (Grant No. 2025-0554-ZD-03); and Foundation of Shanghai Pulmonary Hospital, China (Grant No. LYRC202402, FKLY20004).
Authors
- Shiqi Hu (ORCID: https://orcid.org/0000-0002-8570-3439)
- Yuming Zhu
- Wenxin He (ORCID: https://orcid.org/0000-0002-8249-968X)
- Ying Zhou (ORCID: https://orcid.org/0000-0003-0408-3731)
- Dongliang Bian (ORCID: https://orcid.org/0000-0002-5779-2593)
- Minwei Bao
- Hai Hu (ORCID: https://orcid.org/0000-0002-5348-5641)
- Jie Huang (ORCID: https://orcid.org/0000-0003-2782-2453)
- Xuefei Hu (ORCID: https://orcid.org/0000-0002-1840-7787)
- Huansha Yu (ORCID: https://orcid.org/0000-0001-5516-2128)
- Peng Zhang (ORCID: https://orcid.org/0000-0003-1771-7545)
- Qiji Guo
- Hongyi Zhang (ORCID: https://orcid.org/0000-0003-3408-2959)
- Lele Zhang (ORCID: https://orcid.org/0000-0002-5595-3103)
- Xinsheng Zhu
- Yirui Zhou
- Jincheng Su
- Jie Yang (ORCID: https://orcid.org/0000-0003-1225-983X)
- Yi Bao (ORCID: https://orcid.org/0000-0001-7144-5849)
- Ge Tao (ORCID: https://orcid.org/0000-0003-3724-487X)
- Meixin Teng
- Suyu Wang
Institutions
- Tongji University (CN)
- Shanghai Pulmonary Hospital (CN)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103669
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00